These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 14726137)
21. Agitation Rate and Time for Complete Dissolution in BCS Biowaivers Based on Investigation of a BCS Biowaiver for Dexketoprofen Tablets. Garcia-Arieta A; Gordon J; Gwaza L; Mangas-Sanjuan V; Álvarez C; Torrado JJ Mol Pharm; 2015 Sep; 12(9):3194-201. PubMed ID: 26237401 [TBL] [Abstract][Full Text] [Related]
22. Correlation of dissolution and disintegration results for an immediate-release tablet. Nickerson B; Kong A; Gerst P; Kao S J Pharm Biomed Anal; 2018 Feb; 150():333-340. PubMed ID: 29287259 [TBL] [Abstract][Full Text] [Related]
23. Influence of dissolution media pH and USP1 basket speed on erosion and disintegration characteristics of immediate release metformin hydrochloride tablets. Desai D; Wong B; Huang Y; Tang D; Hemenway J; Paruchuri S; Guo H; Hsieh D; Timmins P Pharm Dev Technol; 2015; 20(5):540-5. PubMed ID: 24621340 [TBL] [Abstract][Full Text] [Related]
24. Development and validation of a discriminating in vitro dissolution method for a poorly soluble drug, olmesartan medoxomil: comparison between commercial tablets. Bajerski L; Rossi RC; Dias CL; Bergold AM; Fröehlich PE AAPS PharmSciTech; 2010 Jun; 11(2):637-44. PubMed ID: 20373150 [TBL] [Abstract][Full Text] [Related]
25. Investigation of the Dissolution Profile of Gliclazide Modified-Release Tablets Using Different Apparatuses and Dissolution Conditions. Skripnik KKS; Riekes MK; Pezzini BR; Cardoso SG; Stulzer HK AAPS PharmSciTech; 2017 Jul; 18(5):1785-1794. PubMed ID: 27800567 [TBL] [Abstract][Full Text] [Related]
26. Gauge repeatability and reproducibility for accessing variability during dissolution testing: a technical note. Gao Z; Moore T; Smith AP; Doub W; Westenberger B; Buhse L AAPS PharmSciTech; 2007 Oct; 8(4):E82. PubMed ID: 18181543 [TBL] [Abstract][Full Text] [Related]
27. A reaction limited in vivo dissolution model for the study of drug absorption: Towards a new paradigm for the biopharmaceutic classification of drugs. Macheras P; Iliadis A; Melagraki G Eur J Pharm Sci; 2018 May; 117():98-106. PubMed ID: 29425862 [TBL] [Abstract][Full Text] [Related]
28. Choice of rotation speed (rpm) for bio-relevant drug dissolution testing using a crescent-shaped spindle. Qureshi SA Eur J Pharm Sci; 2004 Nov; 23(3):271-5. PubMed ID: 15489128 [TBL] [Abstract][Full Text] [Related]
29. Dissolution rate studies from a stationary disk/rotating fluid system. Khoury N; Mauger JW; Howard S Pharm Res; 1988 Aug; 5(8):495-500. PubMed ID: 3244657 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of ethylcellulose as matrices for controlled release drug delivery. Quadir MA; Chanda E; Haider SS; Reza MD; Datta BK Pak J Pharm Sci; 2005 Apr; 18(2):29-34. PubMed ID: 16431395 [TBL] [Abstract][Full Text] [Related]
31. Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test. Takano R; Sugano K; Higashida A; Hayashi Y; Machida M; Aso Y; Yamashita S Pharm Res; 2006 Jun; 23(6):1144-56. PubMed ID: 16715363 [TBL] [Abstract][Full Text] [Related]
32. Regulatory considerations for the classification of video monitoring in dissolution testing. Tieu K; Salt A; Wirges J; Grove GN AAPS PharmSciTech; 2014 Dec; 15(6):1611-8. PubMed ID: 25142822 [TBL] [Abstract][Full Text] [Related]
33. Insight into the Development of Dissolution Media for BCS Class II Drugs: A Review from Quality Control and Prediction of In Vivo Performance Perspectives. Wu C; Liu Y; He Z; Sun J Curr Drug Deliv; 2016; 13(7):1004-1020. PubMed ID: 26725724 [TBL] [Abstract][Full Text] [Related]
34. Hydrodynamic, mass transfer, and dissolution effects induced by tablet location during dissolution testing. Bai G; Armenante PM J Pharm Sci; 2009 Apr; 98(4):1511-31. PubMed ID: 18781589 [TBL] [Abstract][Full Text] [Related]
35. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations. Rasool BK; Fahmy SA; Galeel OW Pak J Pharm Sci; 2012 Oct; 25(4):815-22. PubMed ID: 23009999 [TBL] [Abstract][Full Text] [Related]
36. Hydrodynamic simulation (computational fluid dynamics) of asymmetrically positioned tablets in the paddle dissolution apparatus: impact on dissolution rate and variability. D'Arcy DM; Corrigan OI; Healy AM J Pharm Pharmacol; 2005 Oct; 57(10):1243-50. PubMed ID: 16259752 [TBL] [Abstract][Full Text] [Related]
37. Biopharmaceutics classification systems for new molecular entities (BCS-NMEs) and marketed drugs (BCS-MD): theoretical basis and practical examples. Papadopoulou V; Valsami G; Dokoumetzidis A; Macheras P Int J Pharm; 2008 Sep; 361(1-2):70-7. PubMed ID: 18614303 [TBL] [Abstract][Full Text] [Related]
38. Comparison of statistical analysis and Bayesian Networks in the evaluation of dissolution performance of BCS Class II model drugs. Wilson WI; Peng Y; Augsburger LL J Pharm Sci; 2005 Dec; 94(12):2764-76. PubMed ID: 16258987 [TBL] [Abstract][Full Text] [Related]
39. The biowaiver extension for BCS class III drugs: the effect of dissolution rate on the bioequivalence of BCS class III immediate-release drugs predicted by computer simulation. Tsume Y; Amidon GL Mol Pharm; 2010 Aug; 7(4):1235-43. PubMed ID: 20557130 [TBL] [Abstract][Full Text] [Related]